Adamis Pharms Corp patent expiration

1. Symjepi patent expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US11141540 ADAMIS PHARMS CORP Syringe devices
Oct, 2036

(12 years from now)




Drugs and Companies using EPINEPHRINE ingredient

Market Authorisation Date: 27 September, 2018

Treatment: A method for administering a therapeutic dose of epinephrine

Dosage: SOLUTION

More Information on Dosage

SYMJEPI family patents

Family Patents

2. Zimhi patent expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US11027072 ADAMIS PHARMS CORP Emergency devices
May, 2039

(14 years from now)

US11571518 ADAMIS PHARMS CORP Emergency devices
Jun, 2041

(16 years from now)




Drugs and Companies using NALOXONE HYDROCHLORIDE ingredient

Market Authorisation Date: 15 October, 2021

Treatment: A method for administering a therapeutic dose of an opioid antagonist comprising an emergency syringe device including a window configured to allow the user to view the opioid antagonist in the syring...

Dosage: SOLUTION

More Information on Dosage

ZIMHI family patents

Family Patents